Medline Inc.
L10
| 09/27/2025 | 06/28/2025 | 03/28/2025 | 09/28/2024 | ||
|---|---|---|---|---|---|
| Net Income | 322.00M | 327.50M | 327.50M | 324.00M | |
| Total Depreciation and Amortization | 253.00M | 248.50M | 248.50M | 248.00M | |
| Total Amortization of Deferred Charges | 15.00M | 15.00M | 15.00M | 15.00M | |
| Total Other Non-Cash Items | 45.00M | 99.50M | 99.50M | 73.00M | |
| Change in Net Operating Assets | 1.00M | -251.00M | -251.00M | 62.00M | |
| Cash from Operations | 636.00M | 439.50M | 439.50M | 722.00M | |
| Capital Expenditure | -101.00M | -120.50M | -120.50M | -107.00M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | 3.00M | 3.00M | -890.00M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -1.00M | |
| Cash from Investing | -101.00M | -117.50M | -117.50M | -998.00M | |
| Total Debt Issued | 7.57B | 89.50M | 89.50M | 2.18B | |
| Total Debt Repaid | -7.59B | -99.00M | -99.00M | -2.69B | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -18.00M | -7.50M | -7.50M | -3.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -119.00M | -151.50M | -151.50M | -42.00M | |
| Other Financing Activities | -- | -- | -- | -3.00M | |
| Cash from Financing | -161.00M | -168.50M | -168.50M | -558.00M | |
| Foreign Exchange rate Adjustments | -3.00M | 13.50M | 13.50M | -2.00M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 371.00M | 167.00M | 167.00M | -836.00M | |